Orexigen, Duke, Eisai Strike Foreign IP Deal

Law360, New York (September 19, 2007, 12:00 AM EDT) -- Orexigen Therapeutics Inc., Duke University and Eisai Co Ltd. on Wednesday agreed to a settlement that resolves all foreign aspects of a lawsuit related to the use of zonisamide to treat obesity, which had been filed by Orexigen and Duke against Eisai and was settled in the United States at the end of 2006.

Eisai, Duke and Orexigen have released each other from claims outside the United States that relate to the lawsuit, or certain foreign Duke or Eisai patents that may issue from applications claiming...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.